• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.33% Nasdaq Down 0.19%

    Ligand Pharmaceuticals Incorporated (LGND)

    -NasdaqGM
    81.42 Down 5.88(6.74%) 3:52PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:87.30
    Open:87.37
    Bid:81.42 x 100
    Ask:81.51 x 100
    1y Target Est:95.50
    Beta:0.97
    Next Earnings Date:11-May-15LGND Earnings announcement
    Day's Range:80.60 - 88.39
    52wk Range:41.99 - 90.48
    Volume:667,803
    Avg Vol (3m):398,150
    Market Cap:1.59B
    P/E (ttm):145.39
    EPS (ttm):0.56
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for LGND

    Comparison

    Symbol% ChgMkt Cap
    LGNDDown 6.74%1.59B
    LLYUp 0.30%75.41B
    MRKUp 5.33%170.12B
    RHHBYDown 1.12%N/A

    Key Statistics

    Forward P/E (1 yr):24.93
    P/S (ttm):26.48
    Ex-Dividend Date:02-Jul-10

    Analysts

    Annual EPS Est (Dec-15) :2.13
    Quarterly EPS Est (Mar-15) :0.27
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):0.92

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ligand Pharmaceuticals Incorporated operates as a biotechnology company in the United States. The company’s commercial programs include Promacta, an oral medicine that increases the number of platelets in the blood; Kyprolis that is used for ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback